Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 36

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Antibiotic Treatment for Chronic Rhinosinusitis: Prescription Patterns and Associations With Patient Outcome and the Sinus Microbiota

Lux, Christian A., Wagner Mackenzie, Brett, Johnston, James, Zoing, Melissa, Biswas, Kristi, Taylor, Michael W., Douglas, Richard G.·2020·Frontiers in Microbiology

Abstract

Background: Chronic rhinosinusitis (CRS) is a common and debilitating inflammatory condition of the sinuses, afflicting 5% of the general population. Although antibiotics are frequently prescribed for the medical management of CRS, there is surprisingly little evidence to support their efficacy. In this study, we aimed to establish associations between medication usage, the sinus microbiota and patients’ clinical outcomes. Methods: Antibiotic prescription patterns for the year before sample collection of 156 CRS patients, 45 disease control patients (mostly requiring septoplasty and inferior turbinate reduction) and 35 healthy control subjects were examined and analyzed together with previously published bacterial 16S rRNA gene amplicon data from our group. Results: The highest antibiotic usage was observed among the two CRS patient categories. Despite heavy antibiotic usage, CRS patients’ clinical outcomes as indicated by patient questionnaires and radiologic scores were similar to those patients that did not receive any antibiotics. The sinus microbiota was dominated by members of the bacterial genera Corynebacterium and Staphylococcus in all three cohorts. Bacterial community dispersion as measured by principal coordinate analysis was significantly higher in CRS patients compared to healthy control subjects, but not disease control patients. Pairwise comparisons within cohorts revealed differences in the relative 16S rRNA gene sequence abundances of the genera Staphylococcus and Lawsonella between antibiotic users and non-users. However, overall antibiotic effects were minimal and unpredictable. Conclusion: The unpredictable effects of antibiotic treatment on the sinus microbiota found in this study, together with the lack of differences in patients’ symptom scores between cohorts, do not support preoperative antibiotic treatment for CRS patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmicb.2020.595555

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 59

  1. Akkerman, 2005, Prescribing antibiotics for respiratory tract infections by GPs: management and prescriber characteristics., Br. J. Gen. Pract., 55, 114
  2. Bachert, 2014, ICON: chronic rhinosinusitis., World Allergy Organ., 7, 1, 10.1186/1939-4551-7-25 · DOI · Paper page
  3. Barshak, 2017, The role of infection and antibiotics in chronic rhinosinusitis., Laryngosc. Investig. Otolaryngol., 2, 36, 10.1002/lio2.61 · DOI
  4. Beule, 2015, Epidemiology of chronic rhinosinusitis, selected risk factors, comorbidities, and economic burden., GMS Curr. Top. Otorhinolaryngol. Head Neck Surg., 14, 10.3205/cto000126 · DOI
  5. Biswas, 2019, Comparison of subtyping approaches and the underlying drivers of microbial signatures for chronic rhinosinusitis., mSphere, 4, 10.1128/mSphere.00679-18 · DOI
  6. Biswas, 2015, The nasal microbiota in health and disease: variation within and between subjects., Front. Microbiol., 9, 10.3389/fmicb.2015.00134 · DOI · Paper page
  7. Biswas, 2017, Differentially regulated host proteins associated with chronic rhinosinusitis are correlated with the sinonasal microbiome., Front. Cell. Infect. Microbiol., 7, 10.3389/fcimb.2017.00504 · DOI
  8. Brook, 2017, Chronic Sinusitis Medication [Online].
  9. Cain, 2013, Update on the management of chronic rhinosinusitis., Infect. Drug Resist., 6, 1, 10.2147/IDR.S26134 · DOI
  10. Callahan, 2016, DADA2: high-resolution sample inference from illumina amplicon data., Nat. Methods, 13, 581, 10.1038/nmeth.3869 · DOI · Paper page
  11. Chalermwatanachai, 2018, Chronic rhinosinusitis with nasal polyps is characterized by dysbacteriosis of the nasal microbiota., Sci. Rep., 8, 10.1038/s41598-018-26327-2 · DOI
  12. Chandy, 2019, Clinical guidelines on chronic rhinosinusitis in children., Curr. Allergy Asthma Rep., 19, 10.1007/s11882-019-0845-7 · DOI
  13. Cheng, 2015, The role of macrolide antibiotics in increasing cardiovascular risk., J. Am. Coll. Cardiol., 66, 2173, 10.1016/j.jacc.2015.09.029 · DOI
  14. Dietz de Loos, 2019, Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology., J. Allergy Clin. Immunol., 143, 1207, 10.1016/j.jaci.2018.12.986 · DOI · Paper page
  15. Dubin, 2007, American rhinologic society member survey on “maximal medical therapy” for chronic rhinosinusitis., Am. J. Rhinol., 21, 483, 10.2500/ajr.2007.21.3047 · DOI
  16. Escapa, 2018, New insights into human nostril microbiome from the expanded human oral microbiome database (eHOMD): a resource for the microbiome of the human aerodigestive tract., mSystems, 3, 10.1128/mSystems.00187-18 · DOI · Paper page
  17. Fodor, 2012, The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations., PLoS One, 7, 10.1371/journal.pone.0045001 · DOI · Paper page
  18. Gulliford, 2014, Continued high rates of antibiotic prescribing to adults with respiratory tract infection: survey of 568 uk general practices., BMJ Open, 4, 10.1136/bmjopen-2014-006245 · DOI · Paper page
  19. Head, 2016, Systemic and topical antibiotics for chronic rhinosinusitis., Cochrane Database Syst. Rev., 4, 10.1002/14651858.CD011994.pub2 · DOI
  20. Hoggard, Evidence of microbiota dysbiosis in chronic rhinosinusitis., Int. Forum Allergy Rhinol., 7, 230, 10.1002/alr.21871 · DOI · Paper page
  21. Hoggard, Chronic rhinosinusitis and the evolving understanding of microbial ecology in chronic inflammatory mucosal disease., Clin. Microbiol. Rev., 30, 321, 10.1128/CMR.00060-16 · DOI
  22. Hwang, 2019, Prevalence and risk factors of chronic rhinosinusitis in the elderly population of Korea., Am. J. Rhinol. Allergy, 33, 240, 10.1177/1945892418813822 · DOI
  23. Jain, 2018, The effect of medical treatments on the bacterial microbiome in patients with chronic rhinosinusitis: a pilot study., Int. Forum Allergy Rhinol., 10.1002/alr.22110 · DOI
  24. Jernberg, 2010, Long-term impacts of antibiotic exposure on the human intestinal microbiota., Microbiology, 156, 3216, 10.1099/mic.0.040618-0 · DOI · Paper page
  25. Kennedy, 2013, Chronic rhinosinusitis and antibiotics: the good, the bad, and the ugly., Am. J. Rhinol. Allergy, 27, 467, 10.2500/ajra.2013.27.3960 · DOI
  26. Khan, 2019, Commensal bacteria: an emerging player in defense against respiratory pathogens., Front. Immunol., 10, 10.3389/fimmu.2019.01203 · DOI · Paper page
  27. Kim, 2015, Paired analysis of the microbiota of surface mucus and whole-tissue specimens in patients with chronic rhinosinusitis., Int. Forum Allergy Rhinol., 5, 877, 10.1002/alr.21600 · DOI
  28. Klindworth, 2013, Evaluation of general 16s ribosomal rna gene pcr primers for classical and next-generation sequencing-based diversity studies., Nucleic Acids Res., 41, 10.1093/nar/gks808 · DOI · Paper page
  29. Lim, 2008, Topical antimicrobials in the management of chronic rhinosinusitis: a systematic review., Am. J. Rhinol., 22, 381, 10.2500/ajr.2008.22.3189 · DOI
  30. Lim, 2014, Clinical insights from metagenomic analysis of sputum samples from patients with cystic fibrosis., J. Clin. Microbiol., 52, 425, 10.1128/JCM.02204-13 · DOI
  31. Liu, 2013, Medical therapy reduces microbiota diversity and evenness in surgically recalcitrant chronic rhinosinusitis., Int. Forum Allergy Rhinol., 3, 775, 10.1002/alr.21195 · DOI
  32. Lodato, 2013, Priority Medicines for Europe and the World “a Public Health Approach to Innovation”: Background Paper 6.1 Antimicrobial Resistance.
  33. Lux, 2020, Efficacy of neutral electrolysed water in postoperative chronic rhinosinusitis patients., Int. Forum Allergy Rhinol., 10.1002/alr.22683 · DOI
  34. Malaty, 2016, Medical management of chronic rhinosinusitis in adults., Sinusitis, 1, 76, 10.3390/sinusitis1010076 · DOI
  35. Mangiafico, 2019, Rcompanion: Functions to Support Extension Education Program Evaluation.
  36. Maxfield, 2017, General antibiotic exposure is associated with increased risk of developing chronic rhinosinusitis., Laryngoscope, 127, 296, 10.1002/lary.26232 · DOI
  37. McMurdie, 2013, Phyloseq: an r package for reproducible interactive analysis and graphics of microbiome census data., PLoS One, 8, 10.1371/journal.pone.0061217 · DOI · Paper page
  38. Musa, 2019, Antibiotic sensitivity pattern of bacterial isolates in patients with chronic rhinosinusitis in Kaduna, Nigeria., Int. Arch. Otorhinolaryngol., 23, 152, 10.1055/s-0038-1673676 · doi:10.1055/s-0038-1673676
  39. Oksanen, 2019, Vegan: Community Ecology Package.
  40. Paramasivan, 2019, The international sinonasal microbiome study (ISMS): a multicentre, international characterization of sinonasal bacterial ecology., Allergy, 2020, 2033, 10.1111/all.14276 · DOI
  41. Parasher, 2019, The role of doxycycline in the management of chronic rhinosinusitis with nasal polyps., Am. J. Otolaryngol., 40, 467, 10.1016/j.amjoto.2019.03.004 · DOI
  42. Quast, 2013, The silva ribosomal rna gene database project: improved data processing and web-based tools., Nucleic Acids Res., 41, 590, 10.1093/nar/gks1219 · DOI · Paper page
  43. 2019, R: A Language and Environment for Statistical Computing.
  44. Rom, 2019, The association between disease severity and microbiome in chronic rhinosinusitis., Laryngoscope, 129, 1265, 10.1002/lary.27726 · DOI
  45. Rosenfeld, 2015, Clinical practice guideline (update): adult sinusitis., Otolaryngol. Head Neck Surg., 1, 10.1177/0194599815572097 · DOI · Paper page
  46. Schwartz, 2016, Medical management of chronic rhinosinusitis - an update., Expert Rev. Clin. Pharmacol., 9, 695, 10.1586/17512433.2016.1150780 · DOI
  47. Segata, 2011, Metagenomic biomarker discovery and explanation., Genome Biol., 12, 10.1186/gb-2011-12-6-r60 · DOI · Paper page
  48. Shreiner, 2015, The gut microbiome in health and in disease., Curr. Opin. Gastroenterol., 31, 69, 10.1097/MOG.0000000000000139 · DOI · Paper page
  49. Smith, 2013, National burden of antibiotic use for adult rhinosinusitis., J. Allergy Clin. Immunol., 132, 1230, 10.1016/j.jaci.2013.07.009 · DOI
  50. Sturm, 2019, Infection with lawsonella clevelandensis is easily overlooked using routine microbiology methods: a case of a surgical mesh-associated abscess., Clin. Microbiol., 8
  51. Varvyanskaya, 2014, Efficacy of long-term low-dose macrolide therapy in preventing early recurrence of nasal polyps after endoscopic sinus surgery., Int. Forum Allergy Rhinol., 4, 533, 10.1002/alr.21318 · DOI
  52. Wagner Mackenzie, Detection and quantification of Staphylococcus in chronic rhinosinusitis., Int. Forum Allergy Rhinol., 9, 1462, 10.1002/alr.22425 · DOI
  53. Wagner Mackenzie, Longitudinal study of the bacterial and fungal microbiota in the human sinuses reveals seasonal and annual changes in diversity., Sci. Rep., 9, 10.1038/s41598-019-53975-9 · DOI
  54. Wagner Mackenzie, 2017, Bacterial community collapse: a meta-analysis of the sinonasal microbiota in chronic rhinosinusitis., Environ. Microbiol., 19, 381, 10.1111/1462-2920.13632 · DOI · Paper page
  55. Walker, 2019, What is the most appropriate treatment for chronic rhinosinusitis?, Postgrad. Med. J., 95, 493, 10.1136/postgradmedj-2019-136519 · DOI
  56. Wallwork, 2006, A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis., Laryngoscope, 116, 189, 10.1097/01.mlg.0000191560.53555.08 · DOI · Paper page
  57. Winkel, 2015, Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10 years in the claricor randomised, blinded clinical trial., Int. J. Cardiol., 182, 459, 10.1016/j.ijcard.2015.01.020 · DOI
  58. Wood, 2017, Effectiveness of extensive sinus surgery with post-operative medical management for chronic rhinosinusitis., J. Laryngol. Otol., 131, S19, 10.1017/S0022215116009361 · DOI
  59. Zeng, 2011, Comparison of efficacy of mometasone furoate versus clarithromycin in the treatment of chronic rhinosinusitis without nasal polyps in chinese adults., Am. J. Rhinol. Allergy, 25, 203, 10.2500/ajra.2011.25.3728 · DOI

Cited by

See all 36

Metadata

Authors
Lux, C. A., Wagner Mackenzie, B., Johnston, J., Zoing, M., Biswas, K., Taylor, M. W., & Douglas, R. G.
Venue
Frontiers in Microbiology
Published
2020-12-22
Volume
11
ISSN
1664-302X
Cited by
36
References
4
Funders
Garnett Passe and Rodney Williams Memorial Foundation (91073712790)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antibiotic Treatment for Chronic Rhinosinusitis: Prescription Patterns and Associations With Patient Outcome and the Sinus Microbiota. https://app.cochat.ai/papers/10.3389/fmicb.2020.595555
The paper
Lux, C. A., Wagner Mackenzie, B., Johnston, J., Zoing, M., Biswas, K., Taylor, M. W., & Douglas, R. G. (2020). Antibiotic Treatment for Chronic Rhinosinusitis: Prescription Patterns and Associations With Patient Outcome and the Sinus Microbiota. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2020.595555

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.